cerrar
Tagged with IoT

Interview: Bharat V. Daftary – Chairman & Managing…
Bharat V. Daftary, chairman and MD of Bharat Serums & Vaccines (BSV), a biopharmaceutical company with R&D units in USA, Germany & India…

Keith Thompson – CEO, Cell and Gene Therapy Catapult, UK
Keith Thompson, CEO of the Cell & Gene Therapy Catapult, one of a number of Catapult institutions in the UK designed to help commercialize…

Interview: Terry O'Regan – Vice President and Managing…
Terry O’Regan, VP and managing director at Biogen UK and Ireland, discusses the company’s longstanding commitment to the UK, market access issues,…

Interview: Tony Jones – CEO, One Nucleus, UK
Tony Jones, CEO of One Nucleus, a life sciences membership organization centered on the Greater London-Cambridge-East of England corridor, discusses…

India Pharma Market Facts & Figures Snapshot
India's pharmaceutical sales and forecast from 2013 up to 2021. Between 2017 and 2021, the Indian pharma market is forecasted to grow by a CAGR of…

Interview: Satish Varma – Managing Director, Fermenta…
Satish Varma, managing director of Fermenta Biotech Ltd., one of the world’s largest and leading producers of Vitamin D3, provides insights into the…

Interview: Artur Chabowski – President of Mabion, Poland
Artur Chabowski, president of Mabion, a pioneer Polish biotech player, discusses the historic partnership of their product, MabionCD20 with Mylan for…

Lithuania’s Biotech Potential
Lithuania’s biotech sector has grown by between 20 and 25 percent over the last five years and accounts for over one percent of the entire…

Marina Vasiliou – Managing Director, Biogen Canada
At the company’s 40th anniversary, Biogen’s Canadian head Marina Vasiliou gives an insight into her priorities as new managing director, her…

Indian Biosimilars: Going Global
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs…

Interview: Vatché Bartekian – President, Vantage…
Introducing Vantage BioTrials, a CRO focused on operational excellence with a lean and holistic approach to each project, Vatché Bartekian, president…

Interview: Maciej Wieczorek – President, Celon Pharma,…
Maciej Wieczorek, president of Celon Pharma, discusses the award-winning success of the 2016 IPO on the Warsaw stock exchange and the opportunities…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here